In re: VITAL PHARMACEUTICALS, INC., et al.

CourtUnited States Bankruptcy Court, S.D. Florida.
DecidedMay 29, 2026
Docket22-17842
StatusUnknown

This text of In re: VITAL PHARMACEUTICALS, INC., et al. (In re: VITAL PHARMACEUTICALS, INC., et al.) is published on Counsel Stack Legal Research, covering United States Bankruptcy Court, S.D. Florida. primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In re: VITAL PHARMACEUTICALS, INC., et al., (Fla. 2026).

Opinion

Sr Ma, ey * AO OS aR’ if * □ iD 8 Ss 74 □□□ A swillikg & Sa pisruct OF oe

ORDERED in the Southern District of Florida on May 29, 2026.

Peter D. Russin, Judge United States Bankruptcy Court

UNITED STATES BANKRUPTCY COURT SOUTHERN DISTRICT OF FLORIDA FORT LAUDERDALE DIVISION

In re: Chapter 11 VITAL PHARMACEUTICALS, INC., et al., | Case No. 22-17842-PDR Debtors.

ORDER SUSTAINING OBJECTION TO PUTATIVE CLASS PROOF OF CLAIM AND DECLINING TO APPLY BANKRUPTCY RULE 7023 A consumer stops at a gas station somewhere in America, reaches into a cooler, and pulls out a can of Bang Energy drink. The label promises Super Creatine, a proprietary compound that, according to the manufacturer, delivers the performance benefits of creatine in a uniquely bioavailable form. The consumer pays a few dollars more than she might for an ordinary energy drink and goes on her way. What she does not know, and could not reasonably know, is that the product contains no actual

creatine at all. She has been deceived. Under applicable consumer protection law, she has a claim. That consumer is a creditor of this bankruptcy estate. But she is unlikely to

see a notice published in the Wall Street Journal or the Miami Herald. She is unlikely to retain a bankruptcy attorney. She probably will not file a proof of claim for the two or three dollars in damages. The economics are simply not there. And she is not alone: there are potentially millions of people just like her, small claimants scattered across the country, each with a real but tiny grievance, each individually unlikely to seek to vindicate it in any court. This is the defining problem of the consumer creditor in a large bankruptcy case. Bankruptcy law addresses it in two ways. Understanding both

is essential to resolving the matter before the Court. The first approach is structural. A chapter 11 case is itself a collective proceeding. The automatic stay halts the race to the courthouse. The bar date and claims process provide a centralized mechanism through which every creditor, known or unknown, large or small, may present a claim in a single forum, without a lawyer, at essentially no cost. The pro rata distribution ensures that no creditor is favored

over another of equal priority. Nationwide service of process and a single supervising court manage what would otherwise be thousands of scattered proceedings. In this sense, bankruptcy already provides much of what a class action is designed to deliver: aggregation, centralization, efficiency, and protection against the strategic behavior that race-to-judgment dynamics produce outside of bankruptcy.1 Congress designed it this way deliberately, and the design has been proven very effective. But the Code's structural design has limits. Publication notice in a national

newspaper may be legally adequate, and this Court has found that it was in this case, while remaining practically invisible to a consumer who bought a gas station beverage and has long since thrown away the receipt. The bar date, whatever its formal adequacy, does not actually reach the dispersed consumer creditor whose claim is too small to make the necessary effort. When the individual economic incentive to file a claim is very low, the claims process does not aggregate those claims, it simply allows them to expire.

This is the gap that Bankruptcy Rule 7023 was perhaps designed to fill. By incorporating the procedures of Federal Rule of Civil Procedure 23 into the bankruptcy claims process, Rule 7023 allows a class representative to file a single proof of claim on behalf of all similarly situated creditors, aggregating small claims that would otherwise be uneconomical to prosecute individually.2 The Eleventh Circuit recognized the legitimacy of this device in In re Charter Co., holding that a

1The Gentry court enumerated these structural advantages: “(1) established mechanisms for notice, (2) established mechanisms for managing large numbers of claimants, (3) proceedings centralized in a single court with nationwide service of process, and (4) protection against a race to judgment since all of the debtor's assets are under control of the bankruptcy court.” Gentry v. Siegel, 668 F.3d 83, 92-93 (4th Cir. 2012); see also In re Ephedra Prods. Liab. Litig., 329 B.R. 1, 9 (S.D.N.Y. 2005) (“[S]uperiority of the class action vanishes when the ‘other available method’ is bankruptcy, which consolidates all claims in one forum and allows claimants to file proofs of claim without counsel and at virtually no cost.”).

2The Seventh Circuit captured this dynamic with characteristic directness in In re Am. Reserve Corp., 840 F.2d 487, 489 (7th Cir. 1988): “The combination of contingent claims … and the effort needed to decide whether to pursue an identified claim means that for many small claims, it is class actions or nothing.” class proof of claim is not categorically impermissible and that a motion to apply Rule 7023 is not ripe until a claim objection creates a contested matter under Rule 9014.3 The logic is sound: class treatment in bankruptcy serves the same function as class

treatment outside it, and the bankruptcy process has no structural objection to accommodating it. But Rule 7023 is not self-executing. It is not a right. It is a tool, and like any tool it must be used in the right way at the right time. Bankruptcy Rule 9014 provides that the court may direct application of Rule 7023 to a contested matter.4 That word reflects a considered judgment that the class mechanism, whatever its virtues in aggregating consumer claims, carries costs in the bankruptcy context that the court

must weigh against its benefits. The same structural features that make bankruptcy a collective proceeding, the centralized forum, the bar date, the claims administration process, mean that the justifications for class treatment that are compelling outside bankruptcy are sometimes diminished within it. And the timing of a Rule 7023 request matters enormously, because bankruptcy cases do not stand still. Plans confirm. Estates are administered. Creditors who filed timely claims make decisions,

about voting, treatment, and settlement, in reliance on what the claims pool looks

3 The Eleventh Circuit embraced similar reasoning in In re Charter Co., 876 F.2d 866, 871 (11th Cir. 1989).

4Fed. R. Bankr. P. 9014(c). The permissive language is deliberate and consequential: “may” signals discretion, not obligation. See MSPA Claims 1, LLC v. Kingsway Amigo Ins. Co., 950 F.3d 764, 773– 74 (11th Cir. 2020) (“’may’ cannot, by any rendering, mean ‘must’”). The application of Rule 7023 is accordingly a two-step inquiry: first, whether to apply it at all; second, if yes, whether the proposed class satisfies Federal Rule 23. See Ephedra, 329 B.R. at 5. like at any given moment. Every day that passes after confirmation is a day that reliance interests deepen and the cost of disruption grows. Against that backdrop, this case presents a precise and difficult question:

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Mullane v. Central Hanover Bank & Trust Co.
339 U.S. 306 (Supreme Court, 1950)
American Pipe & Construction Co. v. Utah
414 U.S. 538 (Supreme Court, 1974)
Gac Corporation v. Callahan
681 F.2d 1295 (Eleventh Circuit, 1982)
Robert Gentry v. Alfred Siegel
668 F.3d 83 (Fourth Circuit, 2012)
Alderwoods Group, Inc. v. Reyvis Garcia
682 F.3d 958 (Eleventh Circuit, 2012)
In Re Ephedra Products Liability Litigation
329 B.R. 1 (S.D. New York, 2005)
In Re Bally Total Fitness of Greater New York, Inc.
402 B.R. 616 (S.D. New York, 2009)
In Re Musicland Holding Corp.
362 B.R. 644 (S.D. New York, 2007)
Grady v. Quantegy, Inc. (In Re Quantegy, Inc.)
343 B.R. 689 (M.D. Alabama, 2006)
In Re Bicoastal Corp.
133 B.R. 252 (M.D. Florida, 1991)
Marek v. Lane
134 S. Ct. 8 (Supreme Court, 2013)
MSPA Claims 1, LLC v. Kingsway Amigo Insurance Company
950 F.3d 764 (Eleventh Circuit, 2020)

Cite This Page — Counsel Stack

Bluebook (online)
In re: VITAL PHARMACEUTICALS, INC., et al., Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-vital-pharmaceuticals-inc-et-al-flsb-2026.